<html>
<head>PUBMED IDs for DVC1</head>
<body bgcolor='#C5F0F2'><h1>DVC1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23042607/'>DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage.</a> January 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23042605/'>DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks.</a> January 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23319060/'>DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial.</a> October 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25261934/'>Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features.</a> January 21  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25261893/'>Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.</a> September 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25261878/'>CYP1B1 mutations in patients with primary congenital glaucoma from Saudi Arabia.</a> November 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25557546/'>Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.</a> April 7  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25557530/'>Amyloid polyneuropathy caused by wild-type transthyretin.</a> August 21  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27418463/'>Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101.</a> July 16  2016<br></body></html>
